• Professor George Church is a controversial Harvard University scientist
  • He says gene-editing could help extend the lifespan of human beings in future
  • The scientist is developing mini-brains in a lab for use in future transplants
  • He is also working to engineer pigs that grow human-compatible organs
Humans will one day farm pigs for organs and use brain transplants to cure Parkinson's disease.
That's according to controversial Harvard geneticist Professor George Church, who says advances in DNA technology will soon change the way we live.
The scientist is currently working to create pigs that grow human-compatible organs for transplants, as well as mini-brains that grow in a petri-dish.
In a new interview, he said his work – alongside other gene-editing projects – could help to extend the human lifespan and even reverse the ageing process.

Humans will one day farm pigs for organs and use brain transplants to cure Alzheimer's. That's according to controversial Harvard geneticist Professor George Church (file photo), who says advances in our understanding of DNA will soon change the way we live
Humans will one day farm pigs for organs and use brain transplants to cure Alzheimer's. That's according to controversial Harvard geneticist Professor George Church (file photo), who says advances in our understanding of DNA will soon change the way we live
Speaking to Medium, he claimed several biological routes are being explored to reverse the effects of getting older.
These include attempts to expand the survival of our telomeres - bits of DNA that protect the tips of chromosomes and degrade as we age.
But despite a number of promising advances, Professor Church warned the eventual fix is unlikely to come in the form of a simple pill.
'It would be naive to think that there is going to be one magic bullet, some simple food or drug or absence of food that’s going to do it by itself,' he said.
'Many [techniques] have been shown to work in mice.
'I like the gene therapy approach.'
Part of Professor Church's work involves modifying pig DNA to allow the mammals to grow human-compatible organs that can be used in life-saving transplants.
The scientist - who was among the first to use the gene-editing tool Crispr to modify animal cells - said genetic modification could one day reverse the ageing process (stock image) 
The scientist - who was among the first to use the gene-editing tool Crispr to modify animal cells - said genetic modification could one day reverse the ageing process (stock image) 
Last year, a Harvard team led by the 63-year-old used Crispr gene-editing technology to generate more than a dozen pigs bred without certain viruses that rendered many of their organs unusable for human transplant.
Professor Church believes pig-to-human organ transplant trials could happen by 2021 – a breakthrough that promises to dramatically shorten transplant lists.
Speaking about the research, the geneticist told Medium: 'We have begun trials in nonhuman primates of organs from engineered pigs.
'Some people say, "Oh, you shouldn’t do [genetic] enhancement", but the thing is we do enhancement all the time - to some extent, all aging reversal is enhancement. Vaccines are enhancement.'
Professor Church is also involved in a research project that aims to grow clumps of brain tissue in the lab known as 'organoids'.
His team announced in September they had for the first time successfully produced a brain organoid that grew its own blood vessels – a vital step toward fully functioning, transplantable tissues.
Stunning video shows a strand of DNA being sliced in two
Loaded: 0%
Progress: 0%
0:04
Previous
Play
Skip
Unmute
Current Time
0:04
/
Duration Time
0:47
Fullscreen
Need Text
The scientist said: 'The largest structures we've made are on the order of half a billion cells, which is larger than a mouse brain.
'It’s not really a macho size thing yet; it’s just exploiting the ability to get flow through capillaries.'
Professor Church said the organoids could one day be used to develop treatments for Alzheimer's as well as other new drugs and therapies.
It could also be used to cure Parkinson's by replacing clumps of cells lost to the degenerative disease.
The scientist claimed that using this technique to bolster brain matter and improve someone's IQ would be 'quite safe'.

WHO IS HARVARD GENETICIST GEORGE CHURCH?

Professor George Church is a controversial geneticist at Harvard University.
The 63-year-old scientist was among the first to modify animal cells using the gene-editing tool Crispr-Cas9.
He is currently working on a number of projects that aim to use genetic modification to develop advanced medical treatments for humans.
Part of Church's work involves modifying pig DNA to allow the mammals to grow human-compatible organs that can be used in life-saving transplants.
Last year, a Harvard team led by the scientist used Crispr gene-editing to generate more than a dozen pigs bred without certain viruses that had rendered many of their organs unusable for human transplant.
Church believes pig-to-human organ transplant trials could happen by 2021 - a breakthrough that promises to dramatically shorten transplant lists.
Professor Church is also involved in a research project that aims to grow clumps of brain tissue in the lab known as 'organoids'.
His team announced in September they had successfully produced a brain organoid that grew its own blood vessels for the first time - a vital step toward fully functioning, transplantable tissues.
But his breakthroughs have caused some controversies, with some questioning the ethical ramifications of Church's work.
Professor Church was among the first to modify animal cells using the controversial gene-editing tool Crispr-Cas9, and is lead scientist for 'Woolly Mammoth Revival project' – which aims to use the tool to resurrect the extinct creature.
The scientist claims he can inset mammoth genes into an Asian elephant embryo to create a mammoth-elephant hybrid by 2020.
Researchers have called the effort a 'massive ethical issue' and questioned how the new animal would fit into modern ecosystems.His controversial projects have repeatedly hit headlines over the course of a research career spanning more than four decades.
Professor Church was among the first to modify animal cells using the controversial gene-editing tool Crispr-Cas9, and is lead scientist for 'Woolly Mammoth Revival project' – which aims to use the tool to resurrect the extinct creature.
The scientist claims he can inset mammoth genes into an Asian elephant embryo to create a mammoth-elephant hybrid by 2020.
Researchers have called the effort a 'massive ethical issue' and questioned how the new animal would fit into modern ecosystems.
Professor Church has previously said studying Neanderthals cloned from ancient bone DNA could help scientists better understand how the human mind works.
Such experiments would pose a host of ethical concerns – including whether they would be treated as mere study subjects or as beings with their own rights.

WHAT IS CRISPR-CAS9?

CRISPR-Cas9 is a tool for making precise edits in DNA, discovered in bacteria.
The acronym stands for 'Clustered Regularly Inter-Spaced Palindromic Repeats'.
The technique involves a DNA cutting enzyme and a small tag which tells the enzyme where to cut.
The CRISPR/Cas9 technique uses tags which identify the location of the mutation, and an enzyme, which acts as tiny scissors, to cut DNA in a precise place, allowing small portions of a gene to be removed
The CRISPR/Cas9 technique uses tags which identify the location of the mutation, and an enzyme, which acts as tiny scissors, to cut DNA in a precise place, allowing small portions of a gene to be removed
By editing this tag, scientists are able to target the enzyme to specific regions of DNA and make precise cuts, wherever they like.
It has been used to 'silence' genes - effectively switching them off.
When cellular machinery repairs the DNA break, it removes a small snip of DNA.
In this way, researchers can precisely turn off specific genes in the genome.
The approach has been used previously to edit the HBB gene responsible for a condition called β-thalassaemia.